CN100425694C - 诱导胚胎干细胞向胰腺细胞分化的方法 - Google Patents
诱导胚胎干细胞向胰腺细胞分化的方法 Download PDFInfo
- Publication number
- CN100425694C CN100425694C CNB2005100644315A CN200510064431A CN100425694C CN 100425694 C CN100425694 C CN 100425694C CN B2005100644315 A CNB2005100644315 A CN B2005100644315A CN 200510064431 A CN200510064431 A CN 200510064431A CN 100425694 C CN100425694 C CN 100425694C
- Authority
- CN
- China
- Prior art keywords
- cell
- substratum
- differentiation
- activin
- embryo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000004027 cell Anatomy 0.000 title claims abstract description 187
- 230000001939 inductive effect Effects 0.000 title claims abstract description 52
- 238000000034 method Methods 0.000 title claims abstract description 37
- 210000001161 mammalian embryo Anatomy 0.000 title claims abstract description 33
- 210000000130 stem cell Anatomy 0.000 title claims description 19
- 108010023082 activin A Proteins 0.000 claims abstract description 53
- 210000000496 pancreas Anatomy 0.000 claims abstract description 51
- 230000004069 differentiation Effects 0.000 claims abstract description 49
- 210000001671 embryonic stem cell Anatomy 0.000 claims abstract description 34
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 claims abstract description 17
- SHGAZHPCJJPHSC-NUEINMDLSA-N Isotretinoin Chemical compound OC(=O)C=C(C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NUEINMDLSA-N 0.000 claims abstract description 13
- 239000002243 precursor Substances 0.000 claims description 23
- 210000002966 serum Anatomy 0.000 claims description 23
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims description 17
- 108010082117 matrigel Proteins 0.000 claims description 17
- 244000309466 calf Species 0.000 claims description 14
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 12
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 12
- 230000024245 cell differentiation Effects 0.000 claims description 10
- 230000003321 amplification Effects 0.000 claims description 9
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 9
- 229960003966 nicotinamide Drugs 0.000 claims description 8
- 235000005152 nicotinamide Nutrition 0.000 claims description 8
- 239000011570 nicotinamide Substances 0.000 claims description 8
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 230000008859 change Effects 0.000 claims description 4
- 238000012258 culturing Methods 0.000 claims description 2
- 239000001963 growth medium Substances 0.000 claims description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract description 66
- 102000004877 Insulin Human genes 0.000 abstract description 65
- 108090001061 Insulin Proteins 0.000 abstract description 65
- 229940125396 insulin Drugs 0.000 abstract description 33
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 27
- 230000015572 biosynthetic process Effects 0.000 abstract description 11
- 230000006698 induction Effects 0.000 abstract description 9
- 238000011161 development Methods 0.000 abstract description 8
- 238000000338 in vitro Methods 0.000 abstract description 5
- 238000011160 research Methods 0.000 abstract description 5
- 230000007246 mechanism Effects 0.000 abstract description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 50
- 230000014509 gene expression Effects 0.000 description 30
- 210000003734 kidney Anatomy 0.000 description 18
- VOUAQYXWVJDEQY-QENPJCQMSA-N 33017-11-7 Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)CCC1 VOUAQYXWVJDEQY-QENPJCQMSA-N 0.000 description 17
- 108010075254 C-Peptide Proteins 0.000 description 17
- 108090000623 proteins and genes Proteins 0.000 description 17
- 210000002237 B-cell of pancreatic islet Anatomy 0.000 description 16
- 230000035800 maturation Effects 0.000 description 15
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 13
- 241000699670 Mus sp. Species 0.000 description 13
- 238000012136 culture method Methods 0.000 description 13
- 239000008103 glucose Substances 0.000 description 13
- 238000012856 packing Methods 0.000 description 12
- 101100519293 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pdx-1 gene Proteins 0.000 description 11
- 108010048367 enhanced green fluorescent protein Proteins 0.000 description 11
- 230000012010 growth Effects 0.000 description 11
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 description 10
- 108010085895 Laminin Proteins 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 10
- 239000007924 injection Substances 0.000 description 9
- 238000002347 injection Methods 0.000 description 9
- 230000028327 secretion Effects 0.000 description 9
- 229960001052 streptozocin Drugs 0.000 description 9
- 238000003757 reverse transcription PCR Methods 0.000 description 8
- 101150111723 PDX1 gene Proteins 0.000 description 7
- ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 7
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 7
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 7
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 7
- 230000018109 developmental process Effects 0.000 description 7
- 210000004153 islets of langerhan Anatomy 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 229930002330 retinoic acid Natural products 0.000 description 7
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 7
- 238000013016 damping Methods 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- 238000002991 immunohistochemical analysis Methods 0.000 description 6
- 239000003550 marker Substances 0.000 description 6
- 230000004083 survival effect Effects 0.000 description 6
- 108010021582 Glucokinase Proteins 0.000 description 5
- 102000030595 Glucokinase Human genes 0.000 description 5
- 101150068639 Hnf4a gene Proteins 0.000 description 5
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 5
- 238000013459 approach Methods 0.000 description 5
- 230000003914 insulin secretion Effects 0.000 description 5
- 210000003716 mesoderm Anatomy 0.000 description 5
- 150000003384 small molecules Chemical class 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 229960001727 tretinoin Drugs 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 108010010803 Gelatin Proteins 0.000 description 4
- 102100024392 Insulin gene enhancer protein ISL-1 Human genes 0.000 description 4
- 229930003756 Vitamin B7 Natural products 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 238000004043 dyeing Methods 0.000 description 4
- 210000003890 endocrine cell Anatomy 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 239000008273 gelatin Substances 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 235000011852 gelatine desserts Nutrition 0.000 description 4
- 238000012151 immunohistochemical method Methods 0.000 description 4
- 230000009182 swimming Effects 0.000 description 4
- 239000011735 vitamin B7 Substances 0.000 description 4
- 235000011912 vitamin B7 Nutrition 0.000 description 4
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 3
- 101100231576 Drosophila melanogaster Hnf4 gene Proteins 0.000 description 3
- 101001053263 Homo sapiens Insulin gene enhancer protein ISL-1 Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 101150116689 Slc2a2 gene Proteins 0.000 description 3
- 241000269370 Xenopus <genus> Species 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000002771 cell marker Substances 0.000 description 3
- 238000002659 cell therapy Methods 0.000 description 3
- 210000001900 endoderm Anatomy 0.000 description 3
- 210000000981 epithelium Anatomy 0.000 description 3
- PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 230000003248 secreting effect Effects 0.000 description 3
- 230000011664 signaling Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000001890 transfection Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 238000002054 transplantation Methods 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- UZOVYGYOLBIAJR-UHFFFAOYSA-N 4-isocyanato-4'-methyldiphenylmethane Chemical compound C1=CC(C)=CC=C1CC1=CC=C(N=C=O)C=C1 UZOVYGYOLBIAJR-UHFFFAOYSA-N 0.000 description 2
- 108010059616 Activins Proteins 0.000 description 2
- 102000005606 Activins Human genes 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 241000252212 Danio rerio Species 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 241000699660 Mus musculus Species 0.000 description 2
- 101100310648 Mus musculus Sox17 gene Proteins 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 108010019160 Pancreatin Proteins 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 239000000488 activin Substances 0.000 description 2
- 230000001464 adherent effect Effects 0.000 description 2
- 230000003460 anti-nuclear Effects 0.000 description 2
- 210000000721 basilar membrane Anatomy 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000021617 central nervous system development Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000010454 developmental mechanism Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- -1 glut2 Proteins 0.000 description 2
- 239000003966 growth inhibitor Substances 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229950004152 insulin human Drugs 0.000 description 2
- 210000002660 insulin-secreting cell Anatomy 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- PJUIMOJAAPLTRJ-UHFFFAOYSA-N monothioglycerol Chemical compound OCC(O)CS PJUIMOJAAPLTRJ-UHFFFAOYSA-N 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 238000011580 nude mouse model Methods 0.000 description 2
- 230000015031 pancreas development Effects 0.000 description 2
- 230000009996 pancreatic endocrine effect Effects 0.000 description 2
- 229940055695 pancreatin Drugs 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 2
- 210000002955 secretory cell Anatomy 0.000 description 2
- 230000019491 signal transduction Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 238000004114 suspension culture Methods 0.000 description 2
- UOFGSWVZMUXXIY-UHFFFAOYSA-N 1,5-Diphenyl-3-thiocarbazone Chemical compound C=1C=CC=CC=1N=NC(=S)NNC1=CC=CC=C1 UOFGSWVZMUXXIY-UHFFFAOYSA-N 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- YCADIXLLWMXYKW-CMDGGOBGSA-N BMS-493 Chemical compound C12=CC(\C=C\C=3C=CC(=CC=3)C(O)=O)=CC=C2C(C)(C)CC=C1C#CC1=CC=CC=C1 YCADIXLLWMXYKW-CMDGGOBGSA-N 0.000 description 1
- 108010001857 Cell Surface Receptors Proteins 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- 206010013530 Diverticula Diseases 0.000 description 1
- 206010013554 Diverticulum Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102100038595 Estrogen receptor Human genes 0.000 description 1
- 102100023374 Forkhead box protein M1 Human genes 0.000 description 1
- 101150112014 Gapdh gene Proteins 0.000 description 1
- 102000051325 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- 108700031316 Goosecoid Proteins 0.000 description 1
- 102000050057 Goosecoid Human genes 0.000 description 1
- 101000882584 Homo sapiens Estrogen receptor Proteins 0.000 description 1
- 101000907578 Homo sapiens Forkhead box protein M1 Proteins 0.000 description 1
- 101000976075 Homo sapiens Insulin Proteins 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 101150070110 Isl1 gene Proteins 0.000 description 1
- 241000283986 Lepus Species 0.000 description 1
- 241000713869 Moloney murine leukemia virus Species 0.000 description 1
- 101100351017 Mus musculus Pax4 gene Proteins 0.000 description 1
- 102000008730 Nestin Human genes 0.000 description 1
- 108010088225 Nestin Proteins 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 101150075928 Pax4 gene Proteins 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- 102000005157 Somatostatin Human genes 0.000 description 1
- 108010056088 Somatostatin Proteins 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 241000269368 Xenopus laevis Species 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 210000003050 axon Anatomy 0.000 description 1
- 210000002459 blastocyst Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 210000003981 ectoderm Anatomy 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 210000004039 endoderm cell Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000000763 evoking effect Effects 0.000 description 1
- 210000002907 exocrine cell Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 210000001647 gastrula Anatomy 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000012528 insulin ELISA Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 102000006240 membrane receptors Human genes 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 210000005055 nestin Anatomy 0.000 description 1
- 230000003076 paracrine Effects 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000002731 protein assay Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 description 1
- 229960000553 somatostatin Drugs 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000011476 stem cell transplantation Methods 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
- C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/44—Thiols, e.g. mercaptoethanol
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/385—Hormones with nuclear receptors of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/52—Fibronectin; Laminin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
Abstract
Description
Claims (11)
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100644315A CN100425694C (zh) | 2005-04-15 | 2005-04-15 | 诱导胚胎干细胞向胰腺细胞分化的方法 |
CA2604189A CA2604189C (en) | 2005-04-15 | 2006-04-14 | Method of inducing embryonic stem cells into pancreatic cells |
JP2008505719A JP2008535503A (ja) | 2005-04-15 | 2006-04-14 | 胚性幹細胞から膵細胞への誘導方法 |
EP06722332A EP1871869A4 (en) | 2005-04-15 | 2006-04-14 | METHOD FOR INDUCING EMBRYONIC STEM CELLS IN PANCREATIC CELLS |
CNA2006800124737A CN101160390A (zh) | 2005-04-15 | 2006-04-14 | 诱导胚胎干细胞为胰腺细胞的方法 |
AU2006233440A AU2006233440B2 (en) | 2005-04-15 | 2006-04-14 | Method of inducing embryonic stem cells into pancreatic cells |
US11/911,378 US7776597B2 (en) | 2005-04-15 | 2006-04-14 | Method of inducing embryonic stem cells into pancreatic cells |
KR1020077026499A KR100999292B1 (ko) | 2005-04-15 | 2006-04-14 | 배아 줄기세포의 췌장세포로의 유도방법 |
PCT/CN2006/000683 WO2006108361A1 (en) | 2005-04-15 | 2006-04-14 | Method of inducing embryonic stem cells into pancreatic cells |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100644315A CN100425694C (zh) | 2005-04-15 | 2005-04-15 | 诱导胚胎干细胞向胰腺细胞分化的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1847394A CN1847394A (zh) | 2006-10-18 |
CN100425694C true CN100425694C (zh) | 2008-10-15 |
Family
ID=37077134
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100644315A Expired - Fee Related CN100425694C (zh) | 2005-04-15 | 2005-04-15 | 诱导胚胎干细胞向胰腺细胞分化的方法 |
CNA2006800124737A Pending CN101160390A (zh) | 2005-04-15 | 2006-04-14 | 诱导胚胎干细胞为胰腺细胞的方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2006800124737A Pending CN101160390A (zh) | 2005-04-15 | 2006-04-14 | 诱导胚胎干细胞为胰腺细胞的方法 |
Country Status (8)
Country | Link |
---|---|
US (1) | US7776597B2 (zh) |
EP (1) | EP1871869A4 (zh) |
JP (1) | JP2008535503A (zh) |
KR (1) | KR100999292B1 (zh) |
CN (2) | CN100425694C (zh) |
AU (1) | AU2006233440B2 (zh) |
CA (1) | CA2604189C (zh) |
WO (1) | WO2006108361A1 (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101962630B (zh) * | 2009-07-23 | 2013-04-10 | 北京大学 | 诱导人胚胎干细胞或人诱导形成的多潜能干细胞向肝细胞分化的方法 |
CN111848744A (zh) * | 2018-09-03 | 2020-10-30 | 洛阳轩智生物科技有限公司 | 表皮干细胞向胰腺细胞分化的改进方法 |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050266554A1 (en) | 2004-04-27 | 2005-12-01 | D Amour Kevin A | PDX1 expressing endoderm |
EP2377922B1 (en) * | 2004-04-27 | 2020-04-08 | Viacyte, Inc. | PDX1 expressing endoderm |
DK2674485T3 (da) | 2005-10-27 | 2019-08-26 | Viacyte Inc | Pdx-1 udtrykkende dorsal og ventral fortarm endoderm |
JP5122973B2 (ja) * | 2005-11-15 | 2013-01-16 | 独立行政法人科学技術振興機構 | Es細胞からすい臓を生産する方法 |
DK2650360T3 (da) | 2006-03-02 | 2019-10-07 | Viacyte Inc | Endokrine prekursorceller, pancreatiske hormon udtrykkende celler og fremgangsmåder til fremstilling |
US11254916B2 (en) | 2006-03-02 | 2022-02-22 | Viacyte, Inc. | Methods of making and using PDX1-positive pancreatic endoderm cells |
US7695965B2 (en) | 2006-03-02 | 2010-04-13 | Cythera, Inc. | Methods of producing pancreatic hormones |
WO2008013664A2 (en) | 2006-07-26 | 2008-01-31 | Cythera, Inc. | Methods of producing pancreatic hormones |
US9080145B2 (en) | 2007-07-01 | 2015-07-14 | Lifescan Corporation | Single pluripotent stem cell culture |
RU2473685C2 (ru) * | 2007-07-31 | 2013-01-27 | Лайфскен, Инк. | Дифференцировка человеческих эмбриональных стволовых клеток |
WO2009070592A2 (en) | 2007-11-27 | 2009-06-04 | Lifescan, Inc. | Differentiation of human embryonic stem cells |
BR122017025207B1 (pt) | 2008-02-21 | 2021-03-16 | Centocor Ortho Biotech Inc | superfície que faz parte de um recipiente ou matriz destinada para uso em uma cultura de células ou análises, desprovida de uma camada de células alimentadoras e desprovida de uma camada adsorvente |
CA2729121C (en) | 2008-06-30 | 2019-04-09 | Centocor Ortho Biotech Inc. | Differentiation of pluripotent stem cells |
KR101175175B1 (ko) | 2008-07-28 | 2012-08-20 | 서울대학교병원 | 인간 줄기세포에서 고활성 줄기세포를 분리하는 방법 및상기 방법에 의해 분리된 고활성 줄기 세포 |
RU2522001C2 (ru) | 2008-10-31 | 2014-07-10 | Сентокор Орто Байотек Инк. | Дифференцирование человеческих эмбриональных стволовых клеток в линию панкреатических эндокринных клеток |
US9012218B2 (en) | 2008-10-31 | 2015-04-21 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells |
US8278106B2 (en) | 2008-11-14 | 2012-10-02 | Viacyte, Inc. | Encapsulation of pancreatic cells derived from human pluripotent stem cells |
KR101687344B1 (ko) | 2008-11-20 | 2016-12-16 | 얀센 바이오테크 인코포레이티드 | 평면 기재상의 세포 부착 및 배양을 위한 방법 및 조성물 |
CN107267442A (zh) | 2008-11-20 | 2017-10-20 | 詹森生物科技公司 | 微载体上的多能干细胞培养 |
JP2011010653A (ja) * | 2009-06-05 | 2011-01-20 | Kumamoto Univ | 細胞の分化誘導方法 |
KR20170118969A (ko) | 2009-07-20 | 2017-10-25 | 얀센 바이오테크 인코포레이티드 | 인간 배아 줄기 세포의 분화 |
BR112012017761A2 (pt) | 2009-12-23 | 2015-09-15 | Centocor Ortho Biotech Inc | diferenciação das células-tronco embrionárias humanas |
CN102791851B (zh) | 2010-03-01 | 2017-07-14 | 詹森生物科技公司 | 纯化衍生自多能干细胞的细胞的方法 |
JP6050225B2 (ja) | 2010-05-12 | 2016-12-21 | ヤンセン バイオテツク,インコーポレーテツド | ヒト胚性幹細胞の分化 |
ES2585028T3 (es) | 2010-08-31 | 2016-10-03 | Janssen Biotech, Inc. | Diferenciación de células madre pluripotentes |
EP2611910B1 (en) | 2010-08-31 | 2018-01-17 | Janssen Biotech, Inc. | Differentiation of human embryonic stem cells |
ES2660897T3 (es) | 2010-08-31 | 2018-03-26 | Janssen Biotech, Inc. | Diferenciación de células madre embrionarias humanas |
SG11201403473QA (en) | 2011-12-22 | 2014-10-30 | Janssen Biotech Inc | Differentiation of human embryonic stem cells into single hormonal insulin positive cells |
US9434920B2 (en) | 2012-03-07 | 2016-09-06 | Janssen Biotech, Inc. | Defined media for expansion and maintenance of pluripotent stem cells |
US20150140661A1 (en) | 2012-05-25 | 2015-05-21 | Saitama Medical University | Method for producing pancreatic hormone-producing cell, pancreatic hormone-producing cell, and differentiation/induction promoter |
KR102114209B1 (ko) | 2012-06-08 | 2020-05-25 | 얀센 바이오테크 인코포레이티드 | 인간 배아 줄기 세포의 췌장 내분비 세포로의 분화 |
CN111394298A (zh) | 2012-12-31 | 2020-07-10 | 詹森生物科技公司 | 使用hb9调节子使人胚胎干细胞分化为胰腺内分泌细胞的方法 |
CA2896750A1 (en) | 2012-12-31 | 2014-07-03 | Janssen Biotech, Inc. | Suspension and clustering of human pluripotent cells for differentiation into pancreatic endocrine cells |
US10344264B2 (en) | 2012-12-31 | 2019-07-09 | Janssen Biotech, Inc. | Culturing of human embryonic stem cells at the air-liquid interface for differentiation into pancreatic endocrine cells |
US10370644B2 (en) | 2012-12-31 | 2019-08-06 | Janssen Biotech, Inc. | Method for making human pluripotent suspension cultures and cells derived therefrom |
CN103266082A (zh) * | 2013-02-06 | 2013-08-28 | 赛业(广州)生物科技有限公司 | 一种体外诱导胚胎干细胞分化为神经元的方法 |
CN103194424A (zh) * | 2013-03-28 | 2013-07-10 | 于涛 | 一种诱导胚胎干细胞为胰腺组织样细胞的方法 |
WO2014153620A1 (en) * | 2013-03-28 | 2014-10-02 | The University Of Western Australia | METHOD FOR GENERATING MATURE β-LIKE CELLS |
TW201536799A (zh) | 2013-05-24 | 2015-10-01 | Univ Saitama Medical | 新穎之胜肽及其用途 |
SG11201609473XA (en) | 2014-05-16 | 2016-12-29 | Janssen Biotech Inc | Use of small molecules to enhance mafa expression in pancreatic endocrine cells |
CN104988111A (zh) * | 2015-07-08 | 2015-10-21 | 深圳爱生再生医学科技有限公司 | 用于将uc-msc转化为胰岛细胞的诱导液及其应用 |
CN105087468B (zh) * | 2015-09-01 | 2018-12-07 | 东南大学 | 一种高效诱导干细胞向胰岛β样细胞分化的方法 |
MA45479A (fr) | 2016-04-14 | 2019-02-20 | Janssen Biotech Inc | Différenciation de cellules souches pluripotentes en cellules de l'endoderme de l'intestin moyen |
US10767164B2 (en) | 2017-03-30 | 2020-09-08 | The Research Foundation For The State University Of New York | Microenvironments for self-assembly of islet organoids from stem cells differentiation |
CN108913649B (zh) * | 2018-07-27 | 2022-06-07 | 中国人民解放军军事科学院军事医学研究院 | 表达Pdx1/insulin双报告基因的诱导多能干细胞系的构建及其应用 |
CN115029299B (zh) * | 2018-11-07 | 2023-11-14 | 杭州瑞普晨创科技有限公司 | JAK2抑制剂在胰岛β细胞诱导分化中的应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002059278A2 (en) * | 2001-01-24 | 2002-08-01 | The Government Of The United States Of America, As Represented By The Secretary Of Department Of Health & Human Services | Differentiation of stem cells to pancreatic endocrine cells |
WO2003050249A2 (en) * | 2001-12-07 | 2003-06-19 | Geron Corporation | Islet cells from human embryonic stem cells |
CN1478888A (zh) * | 2003-07-09 | 2004-03-03 | 暨南大学 | 胚胎干细胞定向诱导分化为肝细胞的方法 |
CN1580246A (zh) * | 2003-08-01 | 2005-02-16 | 中国人民解放军军事医学科学院基础医学研究所 | 一种诱导胚胎干细胞分化为胰岛样细胞的方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4426064B2 (ja) * | 2000-05-31 | 2010-03-03 | 独立行政法人科学技術振興機構 | 脊椎動物の膵臓のインビトロ形成方法 |
JP2003009854A (ja) | 2001-04-09 | 2003-01-14 | Kyowa Hakko Kogyo Co Ltd | エンブリオイドボディ形成方法及びその用途 |
CA2451838A1 (en) * | 2001-05-25 | 2002-12-05 | Cythera, Inc. | Stem cell differentiation |
US20030134303A1 (en) * | 2001-12-11 | 2003-07-17 | Activx Biosciences, Inc, | Adenine nucleotide-binding protein-directed probes, and methods of their synthesis and use |
-
2005
- 2005-04-15 CN CNB2005100644315A patent/CN100425694C/zh not_active Expired - Fee Related
-
2006
- 2006-04-14 WO PCT/CN2006/000683 patent/WO2006108361A1/en active Application Filing
- 2006-04-14 AU AU2006233440A patent/AU2006233440B2/en active Active
- 2006-04-14 CN CNA2006800124737A patent/CN101160390A/zh active Pending
- 2006-04-14 CA CA2604189A patent/CA2604189C/en active Active
- 2006-04-14 EP EP06722332A patent/EP1871869A4/en not_active Withdrawn
- 2006-04-14 US US11/911,378 patent/US7776597B2/en active Active
- 2006-04-14 KR KR1020077026499A patent/KR100999292B1/ko active IP Right Grant
- 2006-04-14 JP JP2008505719A patent/JP2008535503A/ja active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002059278A2 (en) * | 2001-01-24 | 2002-08-01 | The Government Of The United States Of America, As Represented By The Secretary Of Department Of Health & Human Services | Differentiation of stem cells to pancreatic endocrine cells |
WO2003050249A2 (en) * | 2001-12-07 | 2003-06-19 | Geron Corporation | Islet cells from human embryonic stem cells |
CN1478888A (zh) * | 2003-07-09 | 2004-03-03 | 暨南大学 | 胚胎干细胞定向诱导分化为肝细胞的方法 |
CN1580246A (zh) * | 2003-08-01 | 2005-02-16 | 中国人民解放军军事医学科学院基础医学研究所 | 一种诱导胚胎干细胞分化为胰岛样细胞的方法 |
Non-Patent Citations (4)
Title |
---|
干细胞诱导分化为胰岛的研究进展. 贾延劼等.中华内分泌代谢杂志,第20卷第1期. 2004 |
干细胞诱导分化为胰岛的研究进展. 贾延劼等.中华内分泌代谢杂志,第20卷第1期. 2004 * |
胚胎干细胞向胰岛细胞诱导分化的研究. 王波等.国外医学生物医学工程分册,第27卷第2期. 2004 |
胚胎干细胞向胰岛细胞诱导分化的研究. 王波等.国外医学生物医学工程分册,第27卷第2期. 2004 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101962630B (zh) * | 2009-07-23 | 2013-04-10 | 北京大学 | 诱导人胚胎干细胞或人诱导形成的多潜能干细胞向肝细胞分化的方法 |
CN111848744A (zh) * | 2018-09-03 | 2020-10-30 | 洛阳轩智生物科技有限公司 | 表皮干细胞向胰腺细胞分化的改进方法 |
CN111848744B (zh) * | 2018-09-03 | 2021-07-23 | 宁波希诺赛生物科技有限公司 | 表皮干细胞向胰腺细胞分化的改进方法 |
Also Published As
Publication number | Publication date |
---|---|
WO2006108361A8 (en) | 2007-12-27 |
KR100999292B1 (ko) | 2010-12-07 |
JP2008535503A (ja) | 2008-09-04 |
US20080286867A1 (en) | 2008-11-20 |
WO2006108361A1 (en) | 2006-10-19 |
US7776597B2 (en) | 2010-08-17 |
CA2604189A1 (en) | 2006-10-19 |
KR20080003418A (ko) | 2008-01-07 |
EP1871869A1 (en) | 2008-01-02 |
EP1871869A4 (en) | 2009-01-28 |
AU2006233440A1 (en) | 2006-10-19 |
CA2604189C (en) | 2011-02-08 |
CN101160390A (zh) | 2008-04-09 |
CN1847394A (zh) | 2006-10-18 |
AU2006233440B2 (en) | 2010-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100425694C (zh) | 诱导胚胎干细胞向胰腺细胞分化的方法 | |
KR101008868B1 (ko) | 인간 배아 줄기세포 유래의 섬세포 | |
US20040259244A1 (en) | Methods, compositions, and growth and differentiation factors for insulin-producing cells | |
CA2487858A1 (en) | Methods, compositions, and growth and differentiation factors for insulin-producing cells | |
JP2005506074A (ja) | 肝臓の幹細胞および前駆細胞の膵臓機能細胞への転換 | |
Santana et al. | Insulin‐producing cells derived from stem cells: recent progress and future directions | |
Li et al. | Coexpression of Pdx1 and betacellulin in mesenchymal stem cells could promote the differentiation of nestin-positive epithelium-like progenitors and pancreatic islet-like spheroids | |
Konagaya et al. | Reproducible preparation of spheroids of pancreatic hormone positive cells from human iPS cells: An in vitro study | |
Jin et al. | Stepwise differentiation of functional pancreatic β cells from human pluripotent stem cells | |
Li et al. | Islet neogenesis-associated protein-related pentadecapeptide enhances the differentiation of islet-like clusters from human pancreatic duct cells | |
Claiborn et al. | Toward a cell‐based cure for diabetes: advances in production and transplant of beta cells | |
Soto-Gutierrez et al. | Endoderm Induction for Hepatic and Pancreatic Diff erentiation of ES Cells | |
Zou et al. | Isolation and in vitro characterization of pancreatic progenitor cells from the islets of diabetic monkey models | |
RU2430158C1 (ru) | Способ дифференцировки стволовых клеток взрослого человека в клетки, секретирующие инсулин | |
Narayanan et al. | Ductal cell reprograming to insulin-producing cells as a potential beta cell replacement source for islet auto-transplant recipients | |
Mantovani et al. | Pancreatic Stem Cells and Regenerative Medicine of Endocrine Pancreas | |
Bharadwaj et al. | Stem cell’s potential role in the treatment of diabetes mellitus | |
Lumelsky | Pancreatic Differentiation of Pluripotent Stem Cells | |
Samuelson | Sca-1 positive pancreatic progenitor cells: a replacement for transplanted islets | |
Tadros | Induction of Human Pancreatic Mesenchymal Stem Cells | |
Roche et al. | Stem Cell Approaches for b-cell Replacement |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: BEIJING HUAYUAN FIBERXON TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: PEKING UNIVERSITY Effective date: 20081010 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20081010 Address after: Beijing City, Haidian District Zhongguancun South Street No. 6 Zhucheng building room 615 Patentee after: Beijing Huayuan Bochuang Technology Co., Ltd. Address before: No. 5, the Summer Palace Road, Beijing, Haidian District, Peking University Patentee before: Peking University |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20081015 Termination date: 20150415 |
|
EXPY | Termination of patent right or utility model |